Former Playboy Playmate of the Year, Karen McDougal made the decision to explant -- have her breast implants removed because they were making her sick.

An interesting phenomenon is being reported across the country: Women who believe their breast implants are making them ill say they are struggling to get doctors to listen to them.

The FDA has agreed to hold a public hearing on Breast Implant Illness. CBS 5 investigates concerns the hearings will be stacked to favor implant manufacturers.

Is Facebook pulling a fast one? It appears Facebook may be hiding groups dedicated to breast implant illness.

In-depth searches show not only how many reports were hidden, but also the types of problems with the devices.

After announcing earlier this year they would NOT issue a recall, the FDA is doing an about-face by announcing medical device maker Allergan has agreed to recall it's BIOCELL textured breast implants.

"We are honored that CBS 5 Investigates is helping create a national conversation on breast implant illness," CBS 5 anchor Kris Pickel said. "For decades, sick women have been ignored or portrayed as imagining their symptoms. We listened and investigated their claims."

Textured breast implants made by Allergan were recalled globally this week after the US Food and Drug Administration reported an increased number of cancer cases and deaths linked to the products.

Joanne Chaplin-Shuman survived cancer twice. More than 20 years ago, she was diagnosed with breast cancer and underwent a double mastectomy. Her second round of cancer was caused by the breast implants used in her reconstruction.

The FDA is now acknowledging that women with breast implants may suffer a wide range of symptoms that get may get better when their breasts implants are removed.

PHOENIX, AZ (3TV/CBS 5) - Hundreds of thousands of reports of problems with breast implants have been hidden from the public.

France just became the first country to ban certain textured breast implants linked to a rare type of cancer.

While the panel is not voting on anything, it did discuss possible options regarding what changes – if any -- the FDA can or should make regarding how it handles breast implants.

Women from all over the country went to FDA headquarters in Washington on Monday. 

WASHINGTON (AP) - U.S. health officials are taking another look at the safety of breast implants, the latest review in a decades-long debate.